Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial

Objective To determine whether communicating personalised statin therapy-effects obtained by prognostic algorithm leads to lower decisional conflict associated with statin use in patients with stable cardiovascular disease (CVD) compared with standard (non-personalised) therapy-effects.Design Hypoth...

Full description

Bibliographic Details
Main Authors: Yvo M Smulders, Guy E H M Rutten, Frank L J Visseren, Yolanda van der Graaf, Olga C Damman, Nicole E M Jaspers, Jannick A N Dorresteijn, Corline Brouwers
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/7/e041673.full

Internet

https://bmjopen.bmj.com/content/11/7/e041673.full

Similar Items